{"id":"NCT00811642","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)","officialTitle":"A Multicenter, Open Label Study to Evaluate Safety and Efficacy of Posaconazole Oral Suspension in Treatment of Invasive Fungal Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-11","primaryCompletion":"2010-03","completion":"2010-03","firstPosted":"2008-12-19","resultsPosted":"2011-04-29","lastUpdate":"2017-04-07"},"enrollment":63,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Fungal Infection"],"interventions":[{"type":"DRUG","name":"Posaconazole","otherNames":["Noxafil"]}],"arms":[{"label":"Posaconazole","type":"EXPERIMENTAL"}],"summary":"The purpose of this multicenter, open label study, is to evaluate the safety and efficacy of a 12-week treatment with Posaconazole Oral Suspension in participants with IFI","primaryOutcome":{"measure":"Number of Participants Who Had Clinical Response at 12 Weeks With Posaconazole Treatment","timeFrame":"Treatment week 12","effectByArm":[{"arm":"Posaconazole","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22324990"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":62},"commonTop":["HYPOKALAEMIA","PYREXIA","DIARRHOEA","NAUSEA","RASH"]}}